-+ 0.00%
-+ 0.00%
-+ 0.00%

Anavex reports 77.4-week time saved with oral blarcamesine in AD-004 early Alzheimer’s trial after 144 weeks of treatment

Reuters·03/23/2026 11:29:42

Please log in to view news